Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Lozano

Pediatric Pulmonology Dothan, AL Medical Doctor

NPI 1518915305 CMS profile 1061235

5565 Montgomery Hwy, Dothan, AL 36303

Open in the dashboard

General payments

$6,863

212 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$119,262 paid to institutions, not to them · program year 2025

Through program year 2025, David Lozano of Dothan, AL is reported in the CMS Open Payments database as having received $6,863 across 212 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $119,262 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 88th percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,203 43
2024 General $1,362 44
2023 General $1,113 28
2022 General $2,265 52
2021 General $600 26
2020 General $237 15
2019 General $82 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Lozano
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to David Lozano were reported at $1,203. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year David Lozano Pediatric Pulmonology median Middle half National median
2019 $82 $151 $59–$495 $163
2020 $237 $107 $34–$339 $114
2021 $600 $125 $40–$511 $132
2022 $2,265 $133 $49–$428 $149
2023 $1,113 $138 $44–$494 $160
2024 $1,362 $132 $46–$398 $164
2025 $1,203 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Jazz Pharmaceuticals Inc. $1,612 52 payments
  2. Genzyme Corporation $1,555 16 payments
  3. AstraZeneca Pharmaceuticals LP $1,211 32 payments
  4. Regeneron Healthcare Solutions, Inc. $794 30 payments
  5. Amgen Inc. $448 19 payments
  6. GlaxoSmithKline, LLC. $423 22 payments
  7. Genentech USA, Inc. $142 8 payments
  8. Harmony Biosciences LLC $116 7 payments
  9. Alcresta Therapeutics, Inc. $76 1 payment
  10. Biogen, Inc. $63 3 payments
  11. Other $422 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,340 204 payments
  2. Consulting Fee $930 1 payment
  3. Education $593 7 payments
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $1,468 15 payments
  2. XYWAV $1,334 49 payments
  3. TEZSPIRE Respiratory $1,032 26 payments
  4. DUPIXENT Inflammation And Immunology $714 26 payments
  5. TEZSPIRE Inflammation $414 18 payments
  6. NUCALA $375 20 payments
  7. XYREM $302 7 payments
  8. FASENRA $165 3 payments
  9. Xolair $142 8 payments
  10. DUPIXENT Immunology And Inflammation $80 4 payments
  11. Other $748 37 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

212 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Pulmonology in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record